Inna Thalmann is co-founder and chief operating officer of Mable, a precision medicine company applying genomic sequencing to clinical decision-making. She holds a PhD in Econometrics with a health economics focus from the University of Oxford and completed postdoctoral research on phenotype algorithms for clinical trial design.
Intro paths
YC
Inna went through Y Combinator (Summer 2021) — any YC alum in your network can reach them through the YC community.
→
In turn, Inna can intro founders to Mable's investors below.
Mable's investors · 4
Co-founders
Roman Rothaermel· CEOInna Nicole ThalmannChris EijsboutsKumeren Govnder